Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 26 most recent Form 4 transactions.
| Feb 23 | HALO | Halozyme Therapeutics,… | MEXER | 6,688 | — | — | +18.9% | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | MEXER◆ | 5,332 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | FTAX | 2,876 | $70.98 | $204.1K | -7.5% | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | MEXER | 5,332 | — | — | +16.2% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER◆ | 13,351 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER◆ | 5,329 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER◆ | 5,093 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | FTAX | 7,273 | $79.44 | $577.8K | -18.1% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER | 13,351 | — | — | +49.7% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | FTAX | 2,874 | $79.44 | $228.3K | -9.7% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER | 5,329 | — | — | +21.8% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | FTAX | 2,747 | $79.44 | $218.2K | -10.1% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER | 5,093 | — | — | +23.1% | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 29,502 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 7,448 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 5,167 | — | — | — | Open the original filing on SEC.gov |
| Sep 22, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 314 | $78.67 | $24.7K | -1.4% | Open the original filing on SEC.gov |
| Sep 22, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 1,913 | $77.83 | $148.9K | -7.9% | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | MEXER◷◆ | 1,135 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | MEXER◷◆ | 11,271 | — | — | — | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 13,240 | $75.93 | $1M | -35.3% | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 6,760 | $75.29 | $509K | -15.3% | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | MEXER◷ | 1,135 | $12.49 | $14.2K | +2.6% | Open the original filing on SEC.gov |
| Sep 10, 2025 | HALO | Halozyme Therapeutics,… | MEXER◷ | 11,271 | $12.07 | $136K | +35.3% | Open the original filing on SEC.gov |